Skip to main content
一致魔芋 logo

一致魔芋 — Investor Relations & Filings

Ticker · 920273 ISIN · CNE100005SP4 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 449 across all filing types
Latest filing 2024-03-21 Regulatory Filings
Country CN China
Listing Beijing Stock Exchange 920273

About 一致魔芋

http://www.easykonjac.com/

Hubei Yizhi Konjac Biotechnology Co., Ltd. specializes in the research, development, and large-scale production of konjac-based ingredients and consumer products. The company’s core portfolio includes konjac flour, purified glucomannan, and dietary fibers utilized as functional additives, stabilizers, and gelling agents. Beyond food applications, it develops specialized konjac derivatives for the cosmetic and pharmaceutical sectors, including biodegradable materials and moisturizing components. The firm maintains an integrated industrial chain encompassing raw material sourcing and advanced deep-processing technologies. Its products are designed to meet global standards for health-oriented applications, focusing on low-calorie, high-fiber solutions for weight management and digestive wellness. Through continuous biotechnological innovation, the company provides versatile raw materials and finished goods to diverse international markets.

Recent filings

Filing Released Lang Actions
关于湖北一致魔芋生物科技股份有限公司非经营性资金占用及其他关联资金往来情况的专项审核说明
Regulatory Filings
2024-03-21 Chinese
2023年度审计报告
Regulatory Filings
2024-03-21 Chinese
关于召开2023年年度股东大会通知公告（提供网络投票）
AGM Information Classification · 95% confidence The document is a notice announcing the convening of the 2023 Annual General Meeting (AGM) of 湖北一致魔芋生物科技股份有限公司. It details the meeting date, voting methods, agenda items to be discussed, and procedural information for shareholders. It does not contain the actual annual report or financial statements but references where those reports can be found. The document is primarily an announcement about the AGM and its agenda, not the report itself or voting results. Therefore, it fits the category of AGM Information (AGM-R). The document length is over 5,000 characters and contains detailed AGM-related information, supporting this classification with high confidence.
2024-03-21 Chinese
监事、监事会主席辞职公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the resignation of a supervisory board member and chairman. It details the resignation date, shareholding of the resigning member, reasons for resignation, and the impact on the company's board composition and operations. There is no financial data, no mention of financial results, no regulatory certifications, or report attachments. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board or senior management.
2024-03-21 Chinese
募集资金存放与实际使用情况的专项报告
Capital/Financing Update Classification · 95% confidence The document is titled as a "2023 Annual Special Report on the Deposit and Actual Use of Raised Funds" by 湖北一致魔芋生物科技股份有限公司. It details the total amount of funds raised through stock issuance, the timing of fund receipt, the use of these funds, including investment projects, temporary use of idle funds, and compliance with regulatory requirements. It includes audit opinions and verification reports from accounting firms and mentions regulatory approvals from the China Securities Regulatory Commission. The document is focused on the management and use of capital raised from investors, specifically the raised funds' deposit and usage status for the year 2023. This type of report is a specialized disclosure related to capital raising activities and fund usage, which fits the category of Capital/Financing Update (CAP). It is not a full annual report (10-K), nor an earnings release or management discussion. It is a detailed update on fundraising and capital usage, consistent with the CAP category.
2024-03-21 Chinese
关于2024年度董事、监事、高级管理人员薪酬方案的公告
Remuneration Information Classification · 95% confidence The document is an announcement regarding the 2024 annual remuneration scheme for the company's directors, supervisors, and senior management. It details the salary standards, payment methods, and approval process for the remuneration plan. There is no financial data, audit information, or report content. The document focuses on compensation information for top executives and directors, which fits the Remuneration Information category. The document length is short and it is not a report publication announcement or regulatory filing. Therefore, the appropriate classification is Remuneration Information (DEF 14A).
2024-03-21 Chinese

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.